IMMUNOLOGY

Cross-dressers turn on T cells
Memory T cells remember viruses from previous infections, providing immunity by facilitating the killing of infected cells. For this, they exploit cross-dressing, the transfer of antigens between antigen-presenting cells. See Letter p.629
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A s their name suggests, antigen-presenting cells flag up the presence of foreign molecules (antigens) to killer T cells of the immune system, triggering the appropriate immune response. The cells generally acquire antigens in one of two ways: by direct presentation, in which the cell itself is infected with the antigen it presents; and by cross-presentation, in which the presenting cell engulfs components of an infected cell and then processes and presents the associated antigen. A third mechanism -cross-dressing -has also been postulated [1] [2] [3] , in which an antigen-presenting cell acquires the requisite processed antigen directly from another infected antigenpresenting cell. On page 629 of this issue, Wakim and Bevan 4 report the strongest evidence yet for the relevance of cross-dressing, showing in mice that this process is required for an effective antiviral response.
Humans possess some 100 billion versions of killer (cytotoxic) T cells, each of which carries a T-cell receptor on its cell membrane that recognizes a specific set of antigens. Antigenic peptides of 8-10 residues are presented to T cells as complexes with MHC class I molecules of the immune system. Unnecessary T-cell responses can gravely damage the host by triggering autoimmune effects, so safeguards are in place to prevent this. The most important safeguard is that naive T cellsthose that have not previously been exposed to an antigen -must initially be activated by dendritic cells, a type of antigen-presenting cell. Dendritic cells are present in immune tissues such as the spleen and lymph nodes, and sample the blood and lymphatic system respectively for antigens. They are derived from the bone marrow and specialize in presenting viral and tumour antigens to T cells.
Once activated, T cells replicate at an astonishing speed (a 4-6-hour division time), leading to a 10,000-fold increase in effector-cell numbers within a few days. The effector cells live for weeks, but a subset called memory cells, which constitute only 1% of the cytotoxic T cells in the body, can live for decades. Having run the gauntlet of the activation safeguards as naive cells, memory cells' safeguards for preventing autoimmunity are relaxed, so they can respond more rapidly to an infection. Wakim and Bevan 4 report that memory T cells can be activated through cross-dressing.
If viruses infect dendritic cells, the direct presentation of processed viral proteins can efficiently activate T cells (Fig. 1a) . Many viruses, however, infect only one or a few cell types. They could therefore potentially avoid recognition by not infecting dendritic cells. To prevent this -and to be able to present tumour antigens -dendritic cells use crosspresentation, whereby they acquire antigens from extracellular fluids through the process of endocytosis, or from infected cells either by engulfing them or by the diffusion of antigenic peptides through 'gap junctions' formed between the cells (Fig. 1b) . Cross-presentation seems to be essential for cytotoxic T-cell responses to many viruses 5 . Cross-presentation can also occur by a process called trogocytosis -the transfer of cell-membrane patches or individual proteins between cells 6,7 (Fig. 1c) . This allows antigen presentation by acceptor dendritic cells to occur immediately, without any processing. Such cross-dressing has been demonstrated in proof-of-principle experiments 2, 3 , and Wakim and Bevan confirm that dendritic cells in culture transfer MHC class I-antigen peptide complexes by trogocytosis. Nonetheless, convincingly extending such findings to situations more like those encountered in vivo has remained notoriously difficult. Wakim and Bevan elegantly do just that using chimaeric mice that had received transplanted bone marrow.
To generate the chimaeric animals, the authors used g-irradiation to destroy shortlived bone-marrow-derived cells -including the resident dendritic cells of the spleen and lymph nodes -in normal mice. They then transferred bone-marrow-derived stem cells to these animals from a variety of genetically manipulated mice. In this way, they could distinguish dendritic cells that generate MHC class I-peptide complexes from dendritic cells presenting the class I-peptide complexes to T cells. This revealed that cross-dressed dendritic cells (cells that had acquired the complexes) have a crucial role in activating memory, but not naive, T cells.
How can this selectivity be explained? One possibility is that memory T cells specifically interact with a subset of dendritic cells that are specialized for cross-dressing-based activation. Although Wakim and Bevan show that, in frozen sections of chimaeric spleens, memory and naive cells have a similar anatomical distribution, imaging the tissues of living animals might reveal differences in T-cell localization or behaviour relating to their immunological experience. However, the authors favour another explanation, which indeed seems more likely: that naive T cells, with their high activation threshold, disfavour cross-dressing, which involves the presentation of vanishingly small numbers of MHC class I-antigen complexes.
Whatever the explanation, it will be essential to characterize cross-dressed dendritic cells in more detail, particularly because they belong to a subset of immune cells (CD8 -) that are less adept at many types of cross-presentation than their cytotoxic (CD8 + ) counterparts. What's more, cross-dressing may prove particularly important in cancer immunology, because the killing of infiltrating cross-presenting immune cells by T cells may be crucial for tumour eradication 8 . Although these elegant experiments highlight the biological relevance of cross-dressing, it is likely that, under many circumstances, the standard direct-presentation and crosspresentation pathways are more prevalent. Nevertheless, Wakim and Bevan 4 raise a noteworthy, yet largely neglected, issue: how the activation of memory and naive T cells differs for immune responses ranging from those to acute (sporadic) pathogens such as influenza virus and rotavirus, to persistent pathogens including HIV and hepatitis B and C viruses, and to tumours, where the rules are likely to differ altogether. More generally, their findings illustrate the astounding ability of the immune system to use minimal packets of information to control pathogens that seek to exploit the slightest chinks in our immune armour. ■ Jonathan W. Yewdell 
The sound of silence
There are various ways in which apparently 'silent' DNA mutations -those that don't result in a change in the encoded protein -have untoward consequences. A striking example has emerged in a study of Crohn's disease.
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B
ecause of the structure of the genetic code, many mutations in genes will not obviously affect the resultant protein and are hence considered 'silent' . If they don't affect the protein, silent mutations cannot cause genetic disease. Or can they? There is evidence for a variety of mechanisms 1 whereby these apparently innocuous mutations can be harmful, if not lethal. In a paper in Nature Genetics, Brest and colleagues 2 provide evidence of an example of disruption in which a silent mutation affects the regulation, through microRNA, of the process of making the protein.
To produce a protein, the run of nucleotide bases (A, C, T and G) in DNA that makes up a gene is transcribed into a single-stranded messenger RNA (mRNA). This in turn is translated, by the ribosome, into the string of amino acids that constitute the protein. The mRNA is read in blocks of three bases (codons). The codon TTG, for example, translates as the amino-acid leucine. As there are 64 possible codons but only 20 amino acids encoded, different codons can specify the same amino acid. For example, CTG is also translated as leucine. Silent (synonymous) mutations change one codon to another that specifies the same amino acid (for example CTG↔TTG).
Unlike mutations that change a protein, synonymous mutations are typically not considered as possible causes of genetic disease, in part because there is, at first sight, no reason why so seemingly benign a change should have so serious an effect. Indeed, genomewide searches for disease-causing mutations commonly ignore synonymous changes in functional follow-up studies. This seems reasonable, given that natural selection eliminates new amino-acid-changing mutations from populations much more commonly than it does new synonymous mutations.
Silent mutations can, however, be highly deleterious. Many affect regulatory domains hidden within the mRNA, commonly those controlling splicing -the process in which the mRNA must first be cut up, then resectioned, before translation 3 . Synonymous mutations also influence the way the mRNA folds, which can in turn perturb the translation process 4, 5 . They can affect how fast or how accurately the mRNA is translated 6 , although whether this is a disease-causing mechanism is unknown. Synonymous changes may even change the way the protein folds 7 .
A further possible mode of disruption involves a process in which an mRNA is downregulated by being bound by a short, untranslated RNA. These microRNAs (miRNA) have a sequence that is complementary to a small section of the target mRNA, thereby making, after binding, a small section of double-stranded RNA. RNA with a double-strand section is usually destroyed or otherwise prevented from being translated. A single base mutation in a gene's miRNA pairing region, even if synonymous, would cause a mismatch with the sequence of the miRNA, possibly disrupting normal regulation.
Is it realistic to suppose that a single-base mismatch could have any sizeable effect on an organism's fitness by this mechanism? Two pieces of evidence suggest that it can. Often, miRNA binds, not in the protein-coding body of the mRNA, but in an untranslated region at the terminus of the mRNA. Single mutations in this region are known to modify miRNAbased repression and in turn to be associated with disease 8, 9 . Second, when miRNA binding is within the body of the gene, synonymous positions involved in miRNA-mRNA binding tend to be highly sequence-conserved between species 10 , as would be expected if mutations in the binding residues significantly reduce fitness. In a study of Crohn's disease, Brest and colleagues 2 now provide evidence that silent mutations contribute to disease in this manner.
Crohn's disease is a complex inflammatory disorder of the intestine, and is influenced by many genes. One of these, IRGM, specifies a protein involved in the intracellular removal of bacteria; the persistence of bacteria in cells of the gut lining is a feature of the disease. At a leucine-encoding sequence in this gene, there are two silent variants: CTG or TTG, the C form being the common and ancestral form. In European populations, the T variant is repeatedly associated with Crohn's disease 11 , but why this might be is unknown.
Brest et al. 2 report that a family of miRNAs is highly expressed in the lining of the intestine when there is a gut infection. These miRNAs bind in the part of the mRNA of IRGM that specifies the leucine and thus covers the C/T mutation. The miRNA is a good match for the C variant and hence, usually, the miRNA-mRNA binding has the effect of turning down the level of IRGM protein, allowing precise control of the process of intracellular bac terial digestion. However, the T version is not turned down.
By constructing an artificial version of the
